BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bil JP, Schrooders PA, Prins M, Kouw PM, Klomp JH, Scholing M, Huijbregts LP, Sonder GJ, Waegemaekers TC, de Vries HJ, Meijer W, Zuure FR, Tostmann A. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. Euro Surveill 2018;23. [PMID: 29560855 DOI: 10.2807/1560-7917.ES.2018.23.11.17-00491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Klok S, van Dulm E, Boyd A, Generaal E, Eskander S, Joore IK, van Cleef B, Siedenburg E, Bruisten S, van Duijnhoven Y, Tramper-Stranders G, Prins M. Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infections among undocumented migrants and uninsured legal residents in the Netherlands: A cross-sectional study, 2018-2019. PLoS One 2021;16:e0258932. [PMID: 34714867 DOI: 10.1371/journal.pone.0258932] [Reference Citation Analysis]
2 Azadi B, Dollat M, Troia G, Chalal S, Pasquet-cadre A, Yazdanpanah Y. Voluntary HIV and Viral Hepatitis Testing in Newly Arrived Migrant Men in a First Reception Center in the North of Paris—a Qualitative Study on the Perception and Forms of Participation. Int Migration & Integration. [DOI: 10.1007/s12134-021-00897-z] [Reference Citation Analysis]
3 Duracinsky M, Thonon F, Bun S, Ben Nasr I, Dara AF, Lakhdari S, Coblentz-Baumann L, Lert F, Dimi S, Chassany O. Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study. PLoS One 2020;15:e0235260. [PMID: 32589652 DOI: 10.1371/journal.pone.0235260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Hargreaves S, Nellums LB, Johnson C, Goldberg J, Pantelidis P, Rahman A, Friedland FMedSci JS. Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: A feasibility study. Travel Med Infect Dis 2020;36:101611. [PMID: 32126293 DOI: 10.1016/j.tmaid.2020.101611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Panagiotopoulos T. Screening for infectious diseases in newly arrived migrants in Europe: the context matters. Euro Surveill 2018;23. [PMID: 30017023 DOI: 10.2807/1560-7917.ES.2018.23.28.1800283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Eurosurveillance Editorial Team. Note from the editors: World Tuberculosis Day 2018 and Special issue-Screening and prevention of infectious diseases in newly arrived migrants in Europe. Euro Surveill 2018;23. [PMID: 29589576 DOI: 10.2807/1560-7917.ES.2018.23.12.180322-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Suijkerbuijk AWM, van Hoek AJ, Koopsen J, de Man RA, Mangen MJ, de Melker HE, Polder JJ, de Wit GA, Veldhuijzen IK. Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. PLoS One 2018;13:e0207037. [PMID: 30408079 DOI: 10.1371/journal.pone.0207037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
8 Abbas M, Aloudat T, Bartolomei J, Carballo M, Durieux-Paillard S, Gabus L, Jablonka A, Jackson Y, Kaojaroen K, Koch D, Martinez E, Mendelson M, Petrova-Benedict R, Tsiodras S, Christie D, Saam M, Hargreaves S, Pittet D. Migrant and refugee populations: a public health and policy perspective on a continuing global crisis. Antimicrob Resist Infect Control 2018;7:113. [PMID: 30250735 DOI: 10.1186/s13756-018-0403-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 54] [Article Influence: 9.5] [Reference Citation Analysis]